15-67372375-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001031715.3(IQCH):āc.1018T>Gā(p.Tyr340Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000711 in 1,614,042 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031715.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IQCH | NM_001031715.3 | c.1018T>G | p.Tyr340Asp | missense_variant | 9/21 | ENST00000335894.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IQCH | ENST00000335894.9 | c.1018T>G | p.Tyr340Asp | missense_variant | 9/21 | 1 | NM_001031715.3 | A2 | |
IQCH-AS1 | ENST00000669759.1 | n.121+48960A>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000319 AC: 80AN: 250736Hom.: 0 AF XY: 0.000266 AC XY: 36AN XY: 135546
GnomAD4 exome AF: 0.000737 AC: 1078AN: 1461858Hom.: 3 Cov.: 32 AF XY: 0.000708 AC XY: 515AN XY: 727226
GnomAD4 genome AF: 0.000453 AC: 69AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1018T>G (p.Y340D) alteration is located in exon 9 (coding exon 9) of the IQCH gene. This alteration results from a T to G substitution at nucleotide position 1018, causing the tyrosine (Y) at amino acid position 340 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at